Abstract
Dawson-type heteropolyoxometalate compounds (HPC) P2M18O62 -6 (M= Mo, W) have received increasing attention in the catalytic field due to the combination of redox and acidic properties in the same structure. It has been proved that the introduction of vanadium into the Keggin framework is beneficial for redox catalysis, shifting its activity from acid to redox-dominated.
In this work we prepared and characterized vanadium (V) substituted Wells-Dawson heteropolysalt (WDKV). Fresh solid samples were characterized by 31P MAS-NMR, FTIR, SEM, XRD, TGA and Potentiometric titration measurements. Also, we performed the oxidation of a 1,4-dihydropyridine using WDKV as catalyst in acetonitrile media, with H2O2 as oxidant agent. The optimal procedure is the following: 1 mmol% of WDKV, a ratio 1,4-DHP: H2O2 (1:214) at reflux of acetonitrile. It must be noted that along all reactions, no secondary products were observed.
Keywords: Heteropolycompound, Oxidation, Hydrogen peroxide. 1, 4-dihydropyridine.
Graphical Abstract
Current Catalysis
Title:Vanadium-Substituted Wells-Dawson Potassium Salt as Catalyst for Liquid phase Oxidation of 1,4-dihydropyridine Derivative
Volume: 3 Issue: 2
Author(s): Laura M. Sanchez, Angel G. Sathicq, Graciela T. Baronetti and Horacio J. Thomas
Affiliation:
Keywords: Heteropolycompound, Oxidation, Hydrogen peroxide. 1, 4-dihydropyridine.
Abstract: Dawson-type heteropolyoxometalate compounds (HPC) P2M18O62 -6 (M= Mo, W) have received increasing attention in the catalytic field due to the combination of redox and acidic properties in the same structure. It has been proved that the introduction of vanadium into the Keggin framework is beneficial for redox catalysis, shifting its activity from acid to redox-dominated.
In this work we prepared and characterized vanadium (V) substituted Wells-Dawson heteropolysalt (WDKV). Fresh solid samples were characterized by 31P MAS-NMR, FTIR, SEM, XRD, TGA and Potentiometric titration measurements. Also, we performed the oxidation of a 1,4-dihydropyridine using WDKV as catalyst in acetonitrile media, with H2O2 as oxidant agent. The optimal procedure is the following: 1 mmol% of WDKV, a ratio 1,4-DHP: H2O2 (1:214) at reflux of acetonitrile. It must be noted that along all reactions, no secondary products were observed.
Export Options
About this article
Cite this article as:
Sanchez M. Laura, Sathicq G. Angel, Baronetti T. Graciela and Thomas J. Horacio, Vanadium-Substituted Wells-Dawson Potassium Salt as Catalyst for Liquid phase Oxidation of 1,4-dihydropyridine Derivative, Current Catalysis 2014; 3 (2) . https://dx.doi.org/10.2174/2211544702666131224233041
DOI https://dx.doi.org/10.2174/2211544702666131224233041 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet Our Editorial Board Member:
Current Tissue Engineering (Discontinued) Mechanisms of Thrombosis, Available Treatments and Management Challenges Presented by Thromboangiitis Obliterans
Current Medicinal Chemistry Recent Patents on Eggshell: Shell and Membrane Applications
Recent Patents on Food, Nutrition & Agriculture A Perspective on Stem Cells as Biological Systems that Produce Differentiated Osteoblasts and Odontoblasts
Current Stem Cell Research & Therapy Gingipains, the Major Cysteine Proteinases and Virulence Factors of Porphyromonas gingivalis: Structure, Function and Assembly of Multidomain Protein Complexes
Current Protein & Peptide Science In Situ Gels Based Drug Delivery Systems
Current Drug Therapy Biomaterials for Gene Delivery Atelocollagen-mediated Controlled Release of Molecular Medicines
Current Gene Therapy Peripheral Immune Signatures in Alzheimer Disease
Current Alzheimer Research Oxidative Stress Upregulates PDCD4 Expression in Patients with Gastric Cancer via miR-21
Current Pharmaceutical Design Recent Patents on Cell-based Approaches to Collagen Enrichment and Repair
Recent Patents on Regenerative Medicine Rationalizing the Study of Plants for the Treatment of Oral Pain
Current Chemical Biology Approaches and Recent Trends in Gene Delivery for Treatment of Atherosclerosis
Recent Patents on Drug Delivery & Formulation Therapeutic Applications of Mesenchymal Stem Cells: A Comprehensive Review
Current Stem Cell Research & Therapy Aligned Biomimetic Scaffolds as a New Tendency in Tissue Engineering
Current Stem Cell Research & Therapy Material Couture for Wound Healing and Regeneration: an Overview
Current Pharmaceutical Design Microbial Interaction of Periodontopathic Bacterium Porphyromonas gingivalis and HIV-Possible Causal Link of Periodontal Diseases to AIDS Progression-
Current HIV Research Inhibition of Matrix Metalloproteinases as a Feasible Therapeutic Target in Rheumatoid Arthritis
Current Rheumatology Reviews Peironimev-Plus® in the Treatment of Chronic Inflammation of Tunica Albuginea (Peyronie’s Disease). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued) Vitamins and Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Differentiated Thyroid Carcinoma and Intestinal Polyposis Syndromes
Endocrine, Metabolic & Immune Disorders - Drug Targets